Oncology Biosimilar Monoclonal Antibodies: Expanding Access to Cancer Care
Introduction Cancer remains one of the leading causes of morbidity and mortality worldwide, placing a growing burden on healthcare systems and patients alike. Over the past few decades, monoclonal antibodies (mAbs) have transformed oncology by…